₹ 3,917.90
14.10 (0.36%)
P
Pfizer
₹ 3,917.90
Pfizer EPS Summary
The latest quarterly EPS of Pfizer as of Q2 Sep 2026 stands at ₹68.47. This is a 53.21% growth quarter on quarter and 65.71% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹45.05. It beat the estimate by ₹23.42. For the FY2026 the EPS of Pfizer stands at ₹157.92. This is a 5.88% fall compared with FY2025.
Pfizer EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

